Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Bowering · SciRah

Researcher profile · Semantic Scholar

K. Bowering

Share profile

K. Bowering — researcher profile on SciRah

h-index: 6
Works: 18
Citations: 432

Most-cited papers

Dapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial
S. Matthaei, K. Bowering, K. Rohwedder, Anke Grohl +1 more
2015Diabetes Care140 citations Open access
Semantic Scholar
Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial
K. Bowering, C. Case, J. Harvey, M. Reeves +5 more
2017Diabetes Care108 citations
Semantic Scholar
Adhesive contact media--an update on graft fixation and burn scar management.
R. Davey, K. Wallis, K. Bowering
1991Burns62 citations
Semantic Scholar
Durability and tolerability of dapagliflozin over 52 weeks as add‐on to metformin and sulphonylurea in type 2 diabetes
S. Matthaei, K. Bowering, K. Rohwedder, J. Sugg +2 more
2015Diabetes, obesity and metabolism61 citations
Semantic Scholar
A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti‐hyperglycaemic medication: results of the PARADIGM study
K. Bowering, V. Reed, J. Felício, J. Landry +2 more
2012Diabetic Medicine43 citations
Semantic Scholar
Mealtime fast‐acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin‐resistant Type 2 diabetes
K. Bowering, J. Harvey, J. Kolaczynski, J. Snyder +1 more
2018Diabetic Medicine6 citations Open access
Semantic Scholar
Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc Analysis
K. Bowering, H. Rodbard, D. Russell-Jones, B. Bode +7 more
2018Diabetes Therapy4 citations Open access
Semantic Scholar
Faster-Acting Insulin Aspart vs. Insulin Aspart in Basal-Bolus Therapy Improved Postprandial Glycemic Control in Uncontrolled T2D in the Onset® 2 Trial
K. Bowering, C. Case, J. Harvey, M. Reeves +6 more
20164 citations
Semantic Scholar
Foot Care Diabetes Canada Clinical Practice Guidelines Expert Committee
J. Embil, Z. Albalawi, K. Bowering, E. Trepman
20182 citations
Semantic Scholar
Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943–950. Comment on Bowering et al. Diabetes Care 2017;40:951–957
B. Bode, K. Bowering, D. Russell-Jones
2018Diabetes Care1 citations
Semantic Scholar
Liraglutide + Metformin Combination Therapy in Type 2 Diabetes: Clinical Benefits Associated with Early Use of Liraglutide and with Switching a Sulfonylurea for Liraglutide
K. Bowering, S. Bain, J. Seufert, A. Thomsen +2 more
20121 citations
Semantic Scholar
Baseline nocturnal glucose change: A predictor of the treatment effect of bolus intensification in insulin‐treated type 2 diabetes
A. Peters, M. Piletic, Johan Ejstrud, Karen Salvesen-Sykes +2 more
2019Diabetes, obesity and metabolism0 citations Open access
Semantic Scholar
Die nächtliche Blutzuckerveränderung zu Baseline als Prädiktor des Behandlungseffekts einer Bolus-Intensivierung bei insulinbehandelten Patienten mit Typ 2 Diabetes
T. Siegmund, Karen Salvesen-Sykes, A. Peters, M. Piletic +2 more
2019Diabetologie und Stoffwechsel0 citations
Semantic Scholar
The Impact of Baseline BMI and HbA1c on Glycemic Control After Treatment with Fast-Acting Insulin Aspart in Individuals with Type 2 Diabetes
Victor Milosevski, K. Bowering, B. Bode, S. Harris +4 more
20170 citations
Semantic Scholar
Verbesserung der glykämischen Kontrolle und Verringerung des Körpergewichtes innerhalb von 52 Wochen mit Dapagliflozin als Add-on-Therapie zu Metformin und Sulfonylharnstoff
K. Rohwedder, S. Matthaei, K. Bowering, A. Grohl +1 more
20150 citations
Semantic Scholar
Canadian Practice Assessment in Type 2 Diabetes
Pierre Filteau, R. Aronson, K. Bowering
20130 citations Open access
Semantic Scholar
Evaluating the Management of Type 2 Diabetes in the Primary Care Setting Through a Novel Multi-Step Needs Assessment Process
K. Bowering, S. Harris, Lawrence A Leiter, V. Woo +1 more
20130 citations Open access
Semantic Scholar
Beyond Blood Pressure Control: The DESTINATION study.
K. Bowering, J. Tardif, R. Rigal, M. Vaillancourt
20080 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Bode×6
Invite
B. Bode — researcher profile on SciRah
S. Matthaei×3
Invite
S. Matthaei — researcher profile on SciRah
J. Harvey×3
Invite
J. Harvey — researcher profile on SciRah
S. Harris×3
Invite
S. Harris — researcher profile on SciRah

×3

Invite

M. Piletic — researcher profile on SciRah

K. Rohwedder×2

Invite

K. Rohwedder — researcher profile on SciRah

Invite

S. Parikh — researcher profile on SciRah

Invite

C. Case — researcher profile on SciRah

Invite

M. Reeves — researcher profile on SciRah

Invite

M. Sampson — researcher profile on SciRah

Invite

R. Strzinek — researcher profile on SciRah

Invite

D. Bretler — researcher profile on SciRah